SACRAMENTO, Calif., March 2, 2024 /PRNewswire/ — With Super Tuesday around the corner and the next presidential election looming, many of us are feeling our anxiety rise. If you’ve found yourself tossing and turning at night, unable to relax the tension in your shoulders, or even having stomach discomfort, you’re not imagining things: you might be … Read more
EXETER, N.H., Feb. 29, 2024 /PRNewswire/ — Vapotherm, Inc. (OTCQX: VAPO), (“Vapotherm” or the “Company”), a global medical technology company specializing in the development and commercialization of its proprietary Vapotherm high-velocity therapy® products for patients of all ages experiencing respiratory distress, is pleased to announce the regulatory approval of the HVT 2.0 system in Brazil. … Read more
TAICHUNG, Feb. 24, 2024 /PRNewswire/ — In winter, cardiovascular diseases are more prevalent, which significantly increase the likelihood of arterial blockage. In addition to increasing the possibility of accompanying myocardial infarction or stroke, seniors should be especially cautious about Peripheral Arterial Occlusive Disease (PAOD). In mild cases, impaired walking, numbness and weakness during running are … Read more
DUBLIN, Feb. 23, 2024 /PRNewswire/ — The “Exoskeleton Robots – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Exoskeleton Robots Market to Reach $4.6 Billion by 2030 The global market for Exoskeleton Robots estimated at US$489.9 Million in the year 2022, is projected to reach a revised size of US$4.6 Billion … Read more
Kling reports on advancing pipeline of therapeutic antibodies targeting novel antigens discovered with its best-in-class B-cell screening platform, Kling-Select Progress on in vitro and in vivo validation of two highly specific tumor antigens is reported: CD43s, a sialylated-glyco epitope, and U5snRNP200, an ectopically expressed antigen highly specific for AML blast Lead program KBA1412 is advancing in … Read more
DUBLIN, Feb. 14, 2024 /PRNewswire/ — The “Global Hearing Aids Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The global hearing aids market is forecast to reach $8.55 billion by 2029 from US$6.66 Billion in 2023, growing at a CAGR of 4.25%, . The market growth can be attributed to the growing … Read more
EMERYVILLE, Calif., Feb. 8, 2024 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report fourth quarter and full year 2023 financial results on Thursday, February 22, 2024, after the U.S. financial markets close. Dynavax will host a conference call and live audio webcast on Thursday, … Read more
NEW YORK, Feb. 7, 2024 /PRNewswire/ — The energy-based aesthetic devices market is estimated to grow by USD 1.75 billion from 2022 to 2027 at a CAGR of 8.5% according to Technavio. Alma Lasers GmbH, Bausch Health Co Inc., Candela Corp, Concord Medisys, Cutera Inc., Cynosure LLC, DELEO SAS, EndyMed Medical Ltd, Energist Ltd, Erchonia Corp, Fotona d.o.o, … Read more
Mindvalley je individuálna pohlcujúca aplikácia na osobný rozvoj, spustená na visionOS App Store KUALA LUMPUR, Malajzia, LONDÝN, NEW YORK a LOS ANGELES, 3. februára 2024 /PRNewswire/ — Mindvalley, popredná platforma v oblasti osobného rozvoja, s radosťou oznamuje uvedenie svojej prevratnej pohlcujúcej aplikácie na meditáciu a osobný rozvoj na Vision Pro, revolučnej priestorovej počítačovej náhlavnej súprave od … Read more
WIL-31 is the largest prospective prophylaxis study in VWD WIL-31 is the only study in VWD with a prospective on-demand run-in study as an intra-individual comparator wilate® prophylaxis is highly effective at reducing bleeding rates in children and adults with all types of VWD vs prior on-demand treatment LACHEN, Switzerland, Jan. 22, 2024 /PRNewswire/ — Octapharma … Read more